CClinicalTrials.gg
CompletedNCT05617586DCD_ParentUpdated Nov 15, 2022

Early Development and Diagnostic Trajectories in DCD

An observational study in Developmental Coordination Disorder, sponsored by University Ghent. Completed at 1 site in Belgium. Per ClinicalTrials.gov, last updated 2022-11-15.

Sponsored by University Ghent · Observational

Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
12
Sex
All
01

Study summary

The aim of this study is to map the early development of children with DCD and the diagnostic trajectory in Flanders.

Read the detailed description

The Diagnostic and Statistical manual 5th edition (DSM-V) defines Developmental Coordination Disorder (DCD) as early-onset deficits in acquiring and executing motor coordination skills. These deficits significantly interfere with the performance of activities of daily living and impact on academic productivity, leisure and play.

Although DCD can be identified during preschool, diagnosis generally occurs at primary-school age. Before the age of three (t.i. infancy), some parents already express "something is wrong" with their child albeit DCD is rarely diagnosed within this age-group.

Knowledge on DCD in children before the age of five is limited. The aim of this study is twofold: to explore the early development of children with DCD and to map the diagnostic trajectory of DCD in Flanders.

Design: A qualitative narrative inductive study design by means of audio-recorded in-depth interviews

Sampling: Purposeful maximum variation sampling will be applied.

02

Conditions studied

  • Developmental Coordination Disorder

Browse trials for

Keywords

  • Early Development
  • Diagnostic trajectory
  • Parental report
  • Qualitative study
03

In context

Motor Skills Disorders

94 studies on the registry are indexed under Motor Skills Disorders; 24 are open to participants now.

This study's enrollment of 12 is below the median of 92 across 26 observational studies indexed under Motor Skills Disorders.

Browse Motor Skills Disorders studies →

Lead sponsor

University Ghent is the lead sponsor of 345 studies on the registry; 85 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Parents of children with DCD

Inclusion criteria

  1. Parent or guardian of a child diagnosed with DCD
  2. Diagnosis of DCD within the last two years
  3. Child was max. 12y of age at the moment of DCD diagnosis

Exclusion criteria

Exclusion Criteria:

  1. No severe diseases in early childhood greatly impacting development (cancer, severe accident,...)
  2. Diagnosis outside of Belgium
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
12 participants (actual)
Patient registry
No

Groups and cohorts

  • DCD Parents

    An in-depth interview will be conducted of parents of a child with DCD. Parents will be asked to complete a Developmental Coordination Disorder Questionnaire (DCD-Q).

    Other: In-depth parental interview · Other: Developmental Coordination Disorder Questionnaire (DCD-Q)

Interventions

  • OtherIn-depth parental interview

    A semi-structurerd interview will be conducted of parents with a child diagnosed with DCD. The interview will be audio-recorderded. The audiofile will be transcribed ad-verbatim and analyzed using narrative analysis methods.

  • OtherDevelopmental Coordination Disorder Questionnaire (DCD-Q)

    Parents will be asked to complete the DCD-Q. This will help us describe the sample.

06

What researchers measure

Primary outcomes

  1. Early Developmental characteristics of children with DCD during pregnancy (qualitative research) by means of an interview.

    As we will conduct a qualitative narrative analysis of the interviews, no standardised measurement tools will be used. We will probe for the following fields of interest: - Pregnancy:(fetal movements, birth complications)

    Time frame: 20 interviews (duration: approximately 1.5 to 2 hours) starting from january 2019 to december 2020

  2. Early Developmental characteristics of children with DCD during toddlerhood (qualitative research) by means of an interview.

    As we will conduct a qualitative narrative analysis of the interviews, no standardised measurement tools will be used. We will probe for the following fields of interest: - Todderhood (feeding, cyring, sleeping, milestones, behavior, play)

    Time frame: 20 interviews (duration: approximately 1.5 to 2 hours) starting from january 2019 to december 2020

  3. Early Developmental characteristics of children with DCD (preschooler) (qualitative research) by means of an interview.

    As we will conduct a qualitative narrative analysis of the interviews, no standardised measurement tools will be used. We will probe for the following fields of interest: - Preschooler (interests, motor activities, behavior, friends, fatigue, communication, play)

    Time frame: 20 interviews (duration: approximately 1.5 to 2 hours) starting from january 2019 to december 2020

Secondary outcomes

  1. Diagnostic trajectories of children with DCD in Flanders by means of an interview.

    As we will conduct a qualitative narrative analysis of the interviews, no standardised measurement tools will be used. We will probe for the following field of interest: * Did parents/creche/family/friends/school express concerns which have led to seeking advice/help? Which concerns? * Which advises or what help did parents receive from who? What did they do with them? * Which caregivers did they consult? What were the results/advices? * Who diagnosed the child with DCD? Who was involved? * Which elements led to the diagnosis of DCD? We will map the trajectories leading to a diagnosis of DCD in Flanders.

    Time frame: 20 interviews (duration: approximately 1.5 to 2 hours) starting from january 2019 to december 2020

07

Study locations

1 site
  • Ghent University
    Ghent, 9000, Belgium
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 15, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05617586
Lead sponsor
University Ghent
Responsible party
Sponsor
First posted
Nov 15, 2022
Start date
Jan 15, 2019
Primary completion
Jan 25, 2022
Completion
Jan 25, 2022
Last update
Nov 15, 2022

Study contacts

Amy De Roubaix, Master
principal investigator · University Ghent
Hilde Van Waelvelde, PhD
study chair · University Ghent
Dominique Van De Velde, PhD
study chair · University Ghent

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion